HCV infection, malignancy, and liver transplantation

Transplantation Proceedings

Volumn 35, Issue 3, 2003, Pages 1032-1033

  Zignego, A L ^a   Gragnani, L ^a   Di Pietro, E ^a   Solazzo, V ^a   Puliti, S ^a   Laffi, G ^a   Gentilini, P ^a  

^a Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PROTEIN BAX; PROTEIN BCL 2; VIRUS PROTEIN;

CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHOLESTATIC HEPATITIS; CONFERENCE PAPER; CRYOGLOBULINEMIA; EPSTEIN BARR VIRUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MONOCLONAL IMMUNOGLOBULINEMIA; NONHODGKIN LYMPHOMA; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0038030890     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00257-4     Document Type: Conference Paper

References (11)

1. Fattovich G., Giustina G., Degos F., et al. Gastroenterology. 112:1997;463.
2. Ferri C, Pileri S, Zignego AL: In Geodert NIH Je, NCI, (eds) Infectious Causes of Cancer. Targets for Intervention. Totowa, NJ: The Human Press; 2000, p 349.
3. Bruix J., Sherman M., Llovet J.M., et al. J Hepatol. 35:2001;421.
4. Garcia-Retortillo M., Forns X., Feliu A., et al. Hepatology. 35:2002;680.
5. Zekry A., Bishop G.A., Bowen D.G. Liver Transpl. 8:2002;292.
6. Mazzaferro V., Regalia E., Doci R. N Engl J Med. 334:1996;693.
7. Min A.D., Saxena R., Thung S.N., et al. Am J Gastroenterol. 93:1998;2148.
8. Ferri C., Marzo E., Longombardo G. Blood. 81:1993;1132.
9. Zignego A.L., Brechot C. J Hepatol. 31:1999;369.
10. Zignego A.L., Giannelli F., Marrocchi M.E. Hepatology. 31:2000;474.
11. Zein N.N., Perez R.G., Wiesner R.H. Hepatology. 31:2000;808.